Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2025Journal of Dr NTR University of Health SciencesOpen Access

A comparative study of risk factors of rhino orbital cerebral mucormycosis (ROCM) in COVID-19 patients

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAjoy SodaniRJRahul JainRGRishu Garg

Discussion

Loading...

Member takes

Overview

Comparative study reveals diabetes as a key factor in mucormycosis incidence among COVID-19 patients, indicating changing treatment guidelines may play a role.

Key Points

  • The study aims to assess the risk factors contributing to rhino-orbital-cerebral mucormycosis in COVID-19 patients.
  • Comparative analysis of COVID-19 patients diagnosed with ROCM and those without ROCM
  • Patients divided into ROCM (66) and non-ROCM (132) groups
  • Comparison of demographic profile, co-morbidities, treatment received, and vaccination status
  • Diabetes mellitus and uncontrolled blood sugar were the most significant co-morbidities (91%)
  • Headache was the most common symptom of ROCM, followed by peri-orbital discoloration
  • 97% of ROCM patients received steroids, similar to non-ROCM group (100%)

Cite This Study

Sodani et al. (2025) studied this question.

synapsesocial.com/papers/69255726c0ce034ddc35a3f5https://doi.org/10.4103/jdrntruhs.jdrntruhs_102_22
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Practice of Steam Inhalation at Home - A Major Contributory Risk Factor for Development of Rhino-Orbital Cerebral Mucormycosis (ROCM) in COVID-19 Patients2024 · 1 citations
  2. 2The COVID-19 Pandemic and the Escalation of Rhino-Orbital-Cerebral Mucormycosis: A Retrospective Review2025
  3. 3Scenario of mucormycosis in COVID-19 pandemic era from a tertiary care center in West Bengal2026
  4. 4An Experience with Post Covid-19 Rhino-Orbital Cerebral Mucormycosis with Oral Manifestations: A Retrospective Study2024
  5. 5Anesthesia Management of COVID-19 associated Rhino-Orbito-Cerebral Mucormycosis: A Prospective Observational Study2024